Growing Industry Engagement Alex Therapeutics has secured multiple strategic partnerships with major pharmaceutical companies such as Pfizer, GlaxoSmithKline, and Vicore, demonstrating strong industry validation and opportunities for expanding collaborations in digital therapeutics for complex treatment areas.
Specialized Treatment Focus The company's focus on oncology, rare diseases, and neurodegenerative conditions like Parkinson's and IPF presents targeted sales opportunities for tailored digital health solutions that address emotional distress and treatment adherence.
Innovative Technology Stack Leveraging a robust set of modern web and app development tools, Alex Therapeutics offers scalable, clinically validated digital therapeutics, making it a compelling partner for pharmaceutical companies seeking innovative product development.
Funding and Growth Potential With $5.1 million in funding and a small but agile team, the company is poised for sustained growth and is likely open to new collaborations that can accelerate product development and market reach.
Market Expansion Opportunities Recent partnerships and developments in digital therapeutics for nicotine addiction and Parkinson's disease in Europe suggest ongoing expansion into new therapeutic areas and geographies, presenting substantial sales prospects for complementary solutions and joint ventures.
Alex Therapeutics uses 8 technology products and services including Varnish, Cloudflare, Spring Boot, and more. Explore Alex Therapeutics's tech stack below.
| Alex Therapeutics Email Formats | Percentage |
| First@alextherapeutics.com | 86% |
| First.Last@alextherapeutics.com | 14% |
Technology, Information and InternetStockholm, Sweden11-50 Employees
Alex Therapeutics is a digital health company that partners with pharma to support people with treatment and disease-related mental health challenges through clinically validated companion apps. Alex Therapeutics specializes in oncology and rare diseases, which are typically accompanied by complex treatment regimes and emotional distress.
Company Overview
Funding & FinancialsAlex Therapeutics has raised a total of $5.1M of funding over 4 rounds. Their latest funding round was raised on Mar 03, 2023 in the amount of $5.1M.
Funding & FinancialsAlex Therapeutics has raised a total of $5.1M of funding over 4 rounds. Their latest funding round was raised on Mar 03, 2023 in the amount of $5.1M.
1-888-653-2347 
support@leadiq.com